Deferoxamine
NDC 63323-597 · Fresenius Kabi USA, LLC
Generic nameDEFEROXAMINE MESYLATE
Dosage formINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
RouteINTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Active ingredient(s)DEFEROXAMINE MESYLATE
Strength95 mg/mL
Pharmacologic classIron Chelating Activity [MoA], Iron Chelator [EPC]
Marketing categoryANDA
Packages
63323-597-10 — 1 VIAL in 1 BOX (63323-597-10) / 5.3 mL in 1 VIAL
Billed under HCPCS
J0895 — Injection, deferoxamine mesylate, 500 mg Medicare Part B payment limit (ASP + 6%): $10.02
Related Codes
Same active ingredient
FDA lists these products with the same active ingredient.
0078-0467 — deferoxamine mesylate, 0409-2337 — Deferoxamine Mesylate, 60505-6236 — Deferoxamine mesylate, 60505-6237 — Deferoxamine mesylate, 63323-599 — DEFEROXAMINE MESYLATE, 68083-172 — Deferoxamine mesylate, 68083-173 — Deferoxamine mesylate, 87081-467 — deferoxamine mesylate